Caroline Corner, PhD
Ms. Corner is a Managing Director, Senior Research Analyst at Cantor Fitgerald. She previously held senior research positions at MLV & Co., Pacific Growth Equities and Wells Fargo Securities. Prior to entering equity research, she held engineering and product development positions at Baxter Transfusion Therapies and Eli Lilly and Company. Ms. Corner received her PhD in Biological Engineering from Cornell University and a BS in Biological Systems Engineering from Virginia Tech.